SavedAdd your journal

Journals / İstanbul Kuzey Klinikleri / 2020 / Cilt: 7 - Sayı: 1

Mucinous endometrial cancer: Clinical study of the eleven cases

Işın ÜREYEN
Alper KARALÖK
Osman TÜRKMEN
Soner DÜZGÜNER
Günsu KİMYON
Tolga TAŞÇI
Taner TURAN
Derman BAŞARAN
İpek Nur DÜZGÜNER
Pages
60–64
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The site of recurrence was only in the upper abdominal region.CONCLUSION: Based on our study, mucinous endometrial carcinoma has good prognostic factors, and long term survivalcan be achieved surgically alone in patients with stage I.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: In this study, we analyzed surgico-pathologic factors of mucinous type endometrial carcinoma and examinedits frequency of recurrence.METHODS: In this study, eleven cases, definitely diagnosed as pure mucinous type endometrium carcinoma between January 1993 and May 2013, were reviewed.RESULTS: Of 1640 women with endometrium carcinoma, 11 (0.67%) of them had a mucinous cell type.
📊
Key Findings & Data:Mean age of thestudy group was 55 years.
💡
Conclusion & Impact:The site of recurrence was only in the upper abdominal region.CONCLUSION: Based on our study, mucinous endometrial carcinoma has good prognostic factors, and long term survivalcan be achieved surgically alone in patients with stage I.
🔬Design:Review & Systematic Survey
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: In this study, we analyzed surgico-pathologic factors of mucinous type endometrial carcinoma and examinedits frequency of recurrence.METHODS: In this study, eleven cases, definitely diagnosed as pure mucinous type endometrium carcinoma between January 1993 and May 2013, were reviewed.RESULTS: Of 1640 women with endometrium carcinoma, 11 (0.67%) of them had a mucinous cell type. Mean age of thestudy group was 55 years. According to the FIGO 2009, 10 (90.9%) cases were evaluated as stage I and 1 (9.1%) as stageIIIC1. The presence of lymph node metastasis was noticed in only one (12.5%) of eight patients who underwent lymphadenectomy. In this case, metastasis was detected in the pelvic lymph node. Four patients underwent adjuvant therapy as pelvicradiotherapy. Median follow-up time was 50 months (range, 5–84). Recurrence was observed in one (9.1%) patient with stageIIIC1 endometrial cancer in 30 months after primary surgery. The site of recurrence was only in the upper abdominal region.CONCLUSION: Based on our study, mucinous endometrial carcinoma has good prognostic factors, and long term survivalcan be achieved surgically alone in patients with stage I.

🔖

Cite This Article

ÜREYEN, I., KARALÖK, A., TÜRKMEN, O., DÜZGÜNER, S., KİMYON, G., TAŞÇI, T., TURAN, T., BAŞARAN, D., DÜZGÜNER, İ. N. (2022). Mucinous endometrial cancer: Clinical study of the eleven cases. İstanbul Kuzey Klinikleri, Cilt: 7 - Sayı: 1, 60–64. https://ajindex.com/articles/551335

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359– 86
  2. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10–7
  3. Ross JC, Eifel PJ, Cox RS, Kempson RL, Hendrickson MR. Primary mucinous adenocarcinoma of the endometrium. A clinicopathologic and histochemical study. Am J Surg Pathol 1983;7:715–29
  4. Blaustein A, Kurman R.J. Blaustein’s Pathology of the Female Genital Tract. 5th ed. New York: Springer; 2002
  5. Owusu-Darko S, Rauh-Hain JA, Horowitz NS, Goodman A, Schorge JO, Del Carmen MG. Comparison of outcomes in patients with early-stage mucinous endometrial cancer and those with endometrioid endometrial cancer, with and without adjuvant therapy. J Reprod Med 2014;59:527–33
  6. WHO handbook for reporting results of cancer treatment. WHO Offset Publication. 1979; No:148. Available at: https://apps.who.int/ iris/bitstream/handle/10665/37200/WHO_OFFSET_48.pdf?sequence=1&isAllowed=y. Accessed Dec 9, 2019
  7. Hendrickson M, Ross J, Eifel PJ, Cox RS, Martinez A, Kempson R. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables. Gynecol Oncol 1982;13:373–92
  8. Rauh-Hain JA, Vargas RJ, Clemmer J, Clark RM, Bradford LS, Growdon WB, et al. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis. Am J Clin Oncol 2016;39:43–8
  9. Nucci MR, Prasad CJ, Crum CP, Mutter GL. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance. Mod Pathol 1999;12:1137–42
  10. Tiltman AJ. Mucinous carcinoma of the endometrium. Obstet Gynecol 1980;55:244–7
  11. Czernobilsky B, Katz Z, Lancet M, Gaton E. Endocervical-type epithelium in endometrial carcinoma: a report of 10 cases with emphasis on histochemical methods for differential diagnosis. Am J Surg Pathol 1980;4:481–9
  12. Melhem MF, Tobon H. Mucinous adenocarcinoma of the endometrium: a clinico-pathological review of 18 cases. Int J Gynecol Pathol 1987;6:347–55
  13. Clement PB, Young RH. Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2004;11:117–42
  14. Jalloul RJ, Elshaikh MA, Ali-Fehmi R, Haley MM, Yoon J, Mahan M, et al. Mucinous a